ライフサイエンスコーパス: mesenchymal stem cell

1 last differentiation and bone formation from mesenchymal stem cells.

2 e formed through adipogenesis from precursor mesenchymal stem cells.

3 ) were recently identified as liver-resident mesenchymal stem cells.

4 -1beta in micromass pellet cultures of human mesenchymal stem cells.

5 me of Ewing sarcoma compared with progenitor mesenchymal stem cells.

6 are the mesodermal lineage that derives from mesenchymal stem cells.

7 aling at endoplasmic reticulum (ER) in human mesenchymal stem cells.

8 n of human neural stem cells (NSCs), but not mesenchymal stem cells.

9 support mechanosensitive differentiation of mesenchymal stem cells.

10 dated in experiments using human bone marrow mesenchymal stem cells.

11 s such as dermal fibroblasts and endometrial mesenchymal stem cells.

12 outperform bone marrow-mononuclear cells and mesenchymal stem cells.

13 to adhered cells was demonstrated with human mesenchymal stem cells.

14 PCR in human synovial fibroblasts and murine mesenchymal stem cells.

15 define populations of incisor epithelial and mesenchymal stem cells.

16 As a result, amniotic fluid mesenchymal stem cells acquire responsiveness to WNT9b a

17 ey repair achieved by adipose tissue-derived mesenchymal stem cells (ad-MSCs) is associated with rest

18 intraperitoneal injection of human amniotic mesenchymal stem cells (AFSCs) into a mouse model of OI

19 Human-placenta-derived amniotic mesenchymal stem cells (AMCs) demonstrate unique immunor

20 Thy1(+) cells express all typical mesenchymal stem cell and hepatic progenitor cell marker

21 current emerging evidence that H2S regulates mesenchymal stem cell and T-cell functions.

22 ypes of bone marrow mononuclear cells: CD90+ mesenchymal stem cells and CD45+ CD14+ auto-fluorescent+

23 y also promoted the differentiation of human mesenchymal stem cells and diminished clonogenic surviva

24 s and the recruitment of bone marrow-derived mesenchymal stem cells and fibrocytes.

25 ctivity in primary human bone marrow-derived mesenchymal stem cells and human osteosarcoma-derived ce

26 osteoclasts can be differentiated from hiPSC-mesenchymal stem cells and macrophages when co-cultured

27 The viability of human mesenchymal stem cells and osteoblastic SaOS-2 cells was

28 ified histone signature in lineage-committed mesenchymal stem cells and preadipocytes that pairs H3K4

29 ed osteogenesis of mouse bone marrow-derived mesenchymal stem cells and promotes myogenic induction o

30 review directions and advances in the use of mesenchymal stem cells and their derived hepatocytes for

31 differences in terms of attachment of human mesenchymal stem cells, and allow their differentiation

32 ed SNPs were enriched in enhancers active in mesenchymal stem cells, and analysis of annotated genes

33 he fibrotic liver, human bone marrow-derived mesenchymal stem cells, and human hepatogenic profibroti

34 Proliferation and adhesion assays with mesenchymal stem cells, and measurement of the mean dail

35 Similar findings were obtained with human mesenchymal stem cells, and results were confirmed by ta

36 resident fibroblasts, identified a subset of mesenchymal stem cells, and shown these populations to b

37 ineage commitment of primary mouse and human mesenchymal stem cells, and support the growth of a broa

38 hase 1 trial to determine whether autologous mesenchymal stem cells, applied in a bioabsorbable matri

39 In the bone marrow, mesenchymal stem cells are labeled with GFP in nestin-GF

40 Pericytes, resident fibroblasts, and mesenchymal stem cells are poorly described cell populat

41 Flowthrough c-Kit(-) mesenchymal stem cells are positively selected by surfac

42 ng the cell types under investigation, adult mesenchymal stem cells are widely studied, and in early

43 ls (BMSCs, also known as bone marrow-derived mesenchymal stem cells) are manufactured using many diff

44 allow enzyme-free passaging and expansion of mesenchymal stem cells, as well as isolation of cells po

45 e expression of RANKL and RANKL/OPG ratio by mesenchymal stem cells at 2 h.

46 n of osterix, collagen I, and osteocalcin by mesenchymal stem cells at 7 and 14 d of stimulation and

47 ared to HEK 293 normal cells and bone marrow mesenchymal stem cells (BM-hMSCs).

48 We recently identified CD271(+) bone marrow-mesenchymal stem cells (BM-MSCs) as a potential site of

49 Bone marrow-derived mesenchymal stem cells (BMSCs) have the potential of rep

50 osteogenic potential and senescence of bone mesenchymal stem cells (BMSCs) isolated from a TDO patie

51 ic effect of injections of local bone marrow mesenchymal stem cells (BMSCs) on osteoarthritis (OA) of

52 ce has demonstrated that bone marrow-derived mesenchymal stem cells (BMSCs) showed great potential in

53 ve target cells, such as bone marrow-derived mesenchymal stem cells (BMSCs), remains challenging.

54 tor cells, endothelial progenitor cells, and mesenchymal stem cells can be successfully concurrently

55 global view of phenotypic diversification of mesenchymal stem cell-cardiomyocyte hybrids and associat

56 We found placement of mesenchymal stem cell-coated matrix fistula plugs in 12

57 ting of mature white adipocytes, multipotent mesenchymal stem cells, committed progenitor cells, fibr

58 mouse embryonic fibroblasts and bone marrow mesenchymal stem cells compared with wild-type counterpa

59 We evaluated the therapeutic potential of mesenchymal stem cell-conditioned medium (CM-MSC) as an

60 Conversely, Egr1 overexpression in mesenchymal stem cells decreases beige adipocyte differe

61 tential biomarkers for potency prediction of mesenchymal stem cell-derived and pluripotent stem cell-

62 low extracorporeal CO2 removal technique and mesenchymal stem cell-derived microparticles, have also

63 lance between bone formation, carried out by mesenchymal stem cell-derived osteoblasts, and bone reso

64 ogels, Alakpa et al. (2016) demonstrate that mesenchymal stem cell differentiation is paired to deple

65 in terminating BMP signaling and regulating mesenchymal stem cell differentiation.

66 in vitro, compared with bone marrow-derived mesenchymal stem cells, displayed a 55-fold increase in

67 rmation, demonstrating that mechanosensitive mesenchymal stem cells drive condensation of heterotypic

68 tissue-engineered cultures comprised of rat mesenchymal stem cells dynamically seeded on 85% porous

69 lly or physiologically related cells, namely mesenchymal stem cells, endothelial cells or granulocyte

70 are actively incorporated by endothelial and mesenchymal stem cells ex vivo and in vivo and that the

71 Interestingly, human mesenchymal stem cells exposed in vitro to medium condit

72 Furthermore, these cells presented mesenchymal stem cell features and protected cocultured

73 We here test whether a new population of mesenchymal stem cells from human gingiva (GMSCs), which

74 f endothelial cells, hematopoietic cells and mesenchymal stem cells from muscle tissue.

75 t creation of 4 clones using adipose-derived mesenchymal stem cells from Snuppy as donor cells.

76 Subcutaneous cotransplantation with mesenchymal stem cells from the dental pulp on poly-l-la

77 dons differentiated from bone marrow derived mesenchymal stem cells from young (20-24 years) and old

78 Here, we show that glioma-associated human mesenchymal stem cells (GA-hMSC), a newly identified str

79 d repair to allow for the selection of human mesenchymal stem cells harboring the oncogenic transloca

80 Transplantation of human fetal mesenchymal stem cells has been proposed as skeletal ana

81 Although bone marrow-derived mesenchymal stem cells have been previously assessed for

82 ajor factor VIII (FVIII) synthesis site, and mesenchymal stem cells have been shown to control joint

83 LI by injection of human bone marrow derived mesenchymal stem cells (hBD-MSCs) with or without solubl

84 Human bone marrow mesenchymal stem cells (hBMSCs) and their exosomes can s

85 differentiation of human bone marrow-derived mesenchymal stem cells (hBMSCs) remain unclear.

86 feeder layer of human hair follicle-derived mesenchymal stem cells (hHF-MSCs).

87 s been described to differently affect human mesenchymal stem cell (hMSC) and mouse mesenchymal stem

88 rs have demonstrated that PEDF directs human mesenchymal stem cell (hMSC) commitment to the osteoblas

89 Human mesenchymal stem cell (hMSC) delivery has demonstrated p

90 the physiological role of succinate on human mesenchymal stem cell (hMSC) migration by regulating the

91 Promoting the paracrine effects of human mesenchymal stem cell (hMSC) therapy may contribute to i

92 r mammalian cell culture, specifically human mesenchymal stem cells (hMSC).

93 S scaffolds were toxic to repopulating human mesenchymal stem cells (hMSC).

94 overlap with EWS-FLI1 reduction and WT human mesenchymal stem cells (hMSC).

95 llular matrix mechanical properties on human mesenchymal stem cell (hMSCs) function was investigated.

96 l mechanism licensing transcription in human mesenchymal stem cells (hMSCs) adipogenically primed by

97 ic and vasculogenic differentiation of human mesenchymal stem cells (hMSCs) and endothelial colony-fo

98 y coprinting multiple inks composed of human mesenchymal stem cells (hMSCs) and human neonatal dermal

99 Human mesenchymal stem cells (hMSCs) are a promising tool for

100 Mounting evidence indicated that human mesenchymal stem cells (hMSCs) are responsive not only t

101 ty in both the nematode C. elegans and human mesenchymal stem cells (hMSCs) by disrupting the SKN-1/N

102 elease/recovery of 3T3 fibroblasts and human mesenchymal stem cells (hMSCs) from 3D cultures while ma

103 In this work, human mesenchymal stem cells (hMSCs) from five donors were eva

104 Although human mesenchymal stem cells (hMSCs) have been tested in ische

105 on and chondrogenic differentiation of human mesenchymal stem cells (hMSCs) in a 3D printed poly-(eth

106 ding and osteogenic differentiation of human mesenchymal stem cells (hMSCs) into complex tissue-like

107 RATIONALE: Myocardial delivery of human mesenchymal stem cells (hMSCs) is an emerging therapy fo

108 Cartilage grown from human mesenchymal stem cells (hMSCs) is poorly organized and u

109 ructs seeded with porcine AF cells and human mesenchymal stem cells (hMSCs) showed approximately 2.2-

110 potential of adipose tissue - derived human mesenchymal stem cells (hMSCs) was evaluated in vitro.

111 protein corona on stem cell labeling, human mesenchymal stem cells (hMSCs) were labeled with the abo

112 Here we show that pre-treating human mesenchymal stem cells (hMSCs) with synthetic membrane-a

113 ting growth of multipotent human bone marrow mesenchymal stem cells (hMSCs).

114 MRI, with bone marrow-derived primary human mesenchymal stem cells (hMSCs).

115 OH)D3 on osteogenic differentiation of human mesenchymal stem cells (hMSCs).

116 suggest that mutations in Evc2 affect dental mesenchymal stem cell homeostasis, which further leads t

117 Human umbilical cord mesenchymal stem cells (hUC-MSCs), originating in Wharto

118 oses of allogeneic bone marrow-derived human mesenchymal stem cells identically delivered in patients

119 Importantly, unlike mesenchymal stem cells, iMS cells contribute directly to

120 ion in the synovial fibroblasts or in murine mesenchymal stem cells in a dose- and time-dependent man

121 tion, mediated by a limited number of dental mesenchymal stem cells in Evc2 mutant mice.

122 coordinated manner, including recruitment of mesenchymal stem cells, induction of immune response, in

123 ges in conventional cell culture systems and mesenchymal stem cells inside biomimetic hydrogels that

124 ve been implicated in the differentiation of mesenchymal stem cells into various cell lineages.

125 vation of FFA4 expressed by murine C3H10T1/2 mesenchymal stem cells is required for induced different

126 Mesenchymal stem cells isolated from different dental ti

127 rall diffraction signal, whereas naive human mesenchymal stem cells lack these features.

128 ogenic marker genes in mouse osteoblasts and mesenchymal stem cell-like cells.

129 ibroblast cell-cycle progression in cultured mesenchymal stem cell-like progenitors.

130 in TNBC, specifically within mesenchymal and mesenchymal stem cell-like subtypes, whereas expression

131 e osteoblastogenic effect of 5-Aza-dC in ST2 mesenchymal stem cell line.

132 ofibroblast differentiation of lung resident mesenchymal stem cells (LR-MSC) plays an important role

133 ofibroblast differentiation of lung resident mesenchymal stem cells (LR-MSCs) and in the lung tissues

134 nally, the effect of FGF-10 on lung-resident mesenchymal stem cells (LR-MSCs) has not been studied.

135 their number by symmetric division, express mesenchymal stem cell markers, and generate chondrocytes

136 so expressed a similar phenotypic profile of mesenchymal stem cell markers, except a relatively highe

137 roximity to HLE and maintained expression of mesenchymal stem cell markers.

138 population (BMSCs, also known as BM-derived mesenchymal stem cells), may contribute to the hematolog

139 preadipocytes and mouse bone marrow-derived mesenchymal stem cells (mBMSCs) to evaluate the adipogen

140 and Msx2 genes in mouse bone marrow-derived mesenchymal stem cells (mBMSCs) to regenerate a proximal

141 human mesenchymal stem cell (hMSC) and mouse mesenchymal stem cell (mMSC) immunomodulation and differ

142 igates the efficacy of local and intravenous mesenchymal stem cell (MSC) administration to augment ne

143 gical, epigenetic, and genomic damage and to mesenchymal stem cell (MSC) attrition in vivo.

144 oblasts (MO-EVs) to induce mineralisation in mesenchymal stem cell (MSC) cultures and delineate the u

145 Mesenchymal stem cell (MSC) differentiation is mediated

146 ption factor 2 (RUNX2) are key regulators of mesenchymal stem cell (MSC) differentiation toward adipo

147 tion of a bare 3D gelatin scaffold, to human mesenchymal stem cell (MSC) encapsulation and proliferat

148 ich is non-myogenic, Pax7(-) and express the mesenchymal stem cell (MSC) marker platelet-derived grow

149 ro or in vivo, how they converge to regulate mesenchymal stem cell (MSC) mechanosensing is not fully

150 pore formation from elasticity, we show that mesenchymal stem cell (MSC) osteogenesis in vitro, and c

151 hesive capacity of the surfaces and instruct mesenchymal stem cell (MSC) response.

152 RATIONALE: Virtually all mesenchymal stem cell (MSC) studies assume that therapeu

153 RATIONALE: Potential benefits of mesenchymal stem cell (MSC) therapy in heart failure may

154 The role of patient age in the efficacy of mesenchymal stem cell (MSC) therapy in ischemic cardiomy

155 mulating data support a therapeutic role for mesenchymal stem cell (MSC) therapy; however, there is n

156 mulating data support a therapeutic role for mesenchymal stem cell (MSC) therapy; however, there is n

157 plicated diverse organ-resident perivascular mesenchymal stem cell (MSC)-like cells and bone marrow-M

158 Mesenchymal stem cell (MSC)-like cells reside in the vas

159 Mesenchymal stem cells (MSC) are currently employed for

160 Mesenchymal stem cells (MSC) are promising therapeutics

161 ponse to chemical stimuli from cancer cells, mesenchymal stem cells (MSC) can differentiate into canc

162 graft comprised of human bone marrow-derived mesenchymal stem cells (MSC) combined with CD34+ hematop

163 Global gene expression analysis of mesenchymal stem cells (MSC) derived from single clones

164 Mesenchymal stem cells (MSC) display great proliferative

165 Mesenchymal stem cells (MSC) exert antibacterial activit

166 Mesenchymal stem cells (MSC) have become a promising too

167 Bone marrow-derived mesenchymal stem cells (MSC) have been promoted for mult

168 Mesenchymal stem cells (MSC) have the ability to self-re

169 Mesenchymal stem cells (MSC) reside in bone and are recr

170 Mesenchymal stem cells (MSC) responding to mechanical cu

171 ted the ability of human bone derived marrow mesenchymal stem cells (MSC), and human adipose derived

172 res the generation of signals that stimulate mesenchymal stem cells (MSC), myofibroblasts and fibrobl

173 owth and osteogenic differentiation of human mesenchymal stem cells (MSC).

174 one marrow, where cancer cells interact with mesenchymal stem cells (MSC).

175 The mechanisms underlying mesenchymal stem cells' (MSC) suppressive potency are la

176 ccumulated evidence supports the notion that mesenchymal stem cells (MSCs) act in a paracrine manner,

177 tes suppresses fibrogenesis and desensitizes mesenchymal stem cells (MSCs) against subsequent mechani

178 to evaluate the neuroprotective potential of mesenchymal stem cells (MSCs) against the deleterious im

179 The tumor-homing property of mesenchymal stem cells (MSCs) allows targeted delivery o

180 Mesenchymal stem cells (MSCs) ameliorate SLE symptoms by

181 We previously demonstrated that mesenchymal stem cells (MSCs) ameliorated experimental a

182 mitigate RIPF once it occurs, but recently, mesenchymal stem cells (MSCs) and a drug treatment stimu

183 Both bone marrow-derived mesenchymal stem cells (MSCs) and c-kit(+) cardiac stem

184 The combination of autologous mesenchymal stem cells (MSCs) and cardiac stem cells (CS

185 uman induced pluripotent stem cells (iPSCs), mesenchymal stem cells (MSCs) and human umbilical vein e

186 gth 20nt sgRNAs in stem cells, such as human mesenchymal stem cells (MSCs) and induced pluripotent st

187 Utilizing in vitro studies using human mesenchymal stem cells (MSCs) and MDA-MB231 (OPN+) and M

188 Here, mesenchymal stem cells (MSCs) and their nuclei spread in

189 Mouse BM progenitors and human mesenchymal stem cells (MSCs) appeared to contribute in

190 Bone marrow-derived mesenchymal stem cells (MSCs) are a common precursor of

191 Although mesenchymal stem cells (MSCs) are a promising cell sourc

192 iferation, and osteogenic differentiation of mesenchymal stem cells (MSCs) are all enhanced in cells

193 Mesenchymal stem cells (MSCs) are among the major stem c

194 Mesenchymal stem cells (MSCs) are multipotent cells, whi

195 Mesenchymal stem cells (MSCs) are multipotent stromal ce

196 Mesenchymal stem cells (MSCs) are pluripotent cells that

197 ponse to tissue injury, both macrophages and mesenchymal stem cells (MSCs) are recruited to the site

198 Mesenchymal stem cells (MSCs) are recruited to the tumor

199 Bone marrow derived mesenchymal stem cells (MSCs) are regularly utilized for

200 ts own strengths and weaknesses, we utilized mesenchymal stem cells (MSCs) as a medium to perform for

201 We hypothesized that mesenchymal stem cells (MSCs) attenuate OT and OIH in ra

202 ic gene to PDGFB, another potent mitogen for mesenchymal stem cells (MSCs) but potentially safer than

203 Mesenchymal stem cells (MSCs) by virtue of their tissue

204 Preclinical studies indicate that mesenchymal stem cells (MSCs) can stimulate angiogenesis

205 study, we investigated the potential role of mesenchymal stem cells (MSCs) derived from human MT in t

206 3R(hDM/hDM) bone- and adipose tissue-derived mesenchymal stem cells (MSCs) differentiate into adipocy

207 Mesenchymal stem cells (MSCs) display a therapeutic plas

208 Mesenchymal stem cells (MSCs) display substantial cell-t

209 Although accumulating data support that mesenchymal stem cells (MSCs) enhance the efficacy of ca

210 Adipose-derived (AD) mesenchymal stem cells (MSCs) especially have shown enco

211 Human mesenchymal stem cells (MSCs) exposed to DDT were used t

212 Human mesenchymal stem cells (MSCs) express scavenger receptor

213 Mesenchymal stem cells (MSCs) from condylar subchondral

214 We hypothesized that mesenchymal stem cells (MSCs) from infants born to obese

215 investigated the potential involvement of BM mesenchymal stem cells (MSCs) from ISM patients by the K

216 Mesenchymal stem cells (MSCs) from PDL tissue were isola

217 One model suggests that perisinusoidal mesenchymal stem cells (MSCs) give rise to osteoblasts,

218 The therapeutic potential of mesenchymal stem cells (MSCs) has garnered great attenti

219 Mesenchymal stem cells (MSCs) have been shown to elicit

220 s in endodontic regeneration based on pulpal mesenchymal stem cells (MSCs) have demonstrated promisin

221 Mesenchymal stem cells (MSCs) have multiple properties i

222 Mesenchymal stem cells (MSCs) have potential for reducin

223 the safety and efficacy of allogeneic human mesenchymal stem cells (MSCs) in reducing the time to re

224 We have previously shown that endogenous mesenchymal stem cells (MSCs) in the aged heart are mark

225 is mediated through TKI-mediated priming of mesenchymal stem cells (MSCs) in the bone marrow (BM).

226 n of two human cancer cell types and primary mesenchymal stem cells (MSCs) increases DNA breaks throu

227 Extracellular matrix (ECM) of the human Mesenchymal Stem Cells (MSCs) influences intracellular t

228 factors, on the availability and delivery of mesenchymal stem cells (MSCs) into the root canal system

229 Here, DNA methylation profiling of mesenchymal stem cells (MSCs) obtained from individuals

230 EVs) secreted from human bone marrow-derived mesenchymal stem cells (MSCs) on SE-induced adverse chan

231 Mesenchymal stem cells (MSCs) participate in the repair/

232 Mesenchymal stem cells (MSCs) possess immunoregulatory,

233 Mesenchymal stem cells (MSCs) possess unique immunomodul

234 Mesenchymal stem cells (MSCs) represent promising resour

235 eveloped a culture-based method for inducing mesenchymal stem cells (MSCs) to secrete neurotrophic fa

236 Cell fusion can occur between mesenchymal stem cells (MSCs) transplanted to improve ca

237 we analyzed the role of the lncRNA HOTAIR in mesenchymal stem cells (MSCs) with particular focus on s

238 Pericytes are widely believed to function as mesenchymal stem cells (MSCs), multipotent tissue-reside

239 h factor-beta that increase proliferation of mesenchymal stem cells (MSCs), whereas bone morphogeneti

240 ic of bone marrow- and other non-gut-derived mesenchymal stem cells (MSCs), which are emerging as pot

241 Mammalian teeth harbour mesenchymal stem cells (MSCs), which contribute to tooth

242 Mesenchymal stem cells (MSCs), whose mechanism of action

243 Mesenchymal stem cells (MSCs)-based therapy provides a p

244 differentiation of mouse bone marrow-derived mesenchymal stem cells (MSCs).

245 roles in directing the lineage commitment of mesenchymal stem cells (MSCs).

246 c factors from haematopoietic cells on human mesenchymal stem cells (MSCs).

247 vascular endothelial cells (BMECs) and human mesenchymal stem cells (MSCs).

248 anical cues direct the lineage commitment of mesenchymal stem cells (MSCs).

249 nt tissue samples with endothelial cells and mesenchymal stem cells (MSCs).

250 in stem cell self-renewal, including that of mesenchymal stem cells (MSCs).

251 ate a transgenic approach to magnetize human mesenchymal stem cells (MSCs).

252 etinoids in the osteogenesis of human marrow mesenchymal stem cells (MSCs).

253 lated during chondrogenic differentiation of mesenchymal stem cells (MSCs).

254 direct the fate determination of multipotent mesenchymal stem cells (MSCs).

255 oncolytic herpes simplex virus (oHSV)-armed mesenchymal stem cells (MSCs).

256 nt (PDL) has been reported to be a source of mesenchymal stem cells (MSCs).New vascular networks from

257 rthermore, IL-3 enhances RANKL expression in mesenchymal stem cells of wild-type mice but not in STAT

258 Human embryonic kidney (HEK) cells and ovine mesenchymal stem cells (oMSCs) were printed at tissue-re

259 uld be detected in human bone marrow-derived mesenchymal stem cells or human hepatogenic profibrotic

260 d with any serious adverse events related to mesenchymal stem cells or plug placement.

261 e differentiation and mechanotransduction of mesenchymal stem cells, osteoblasts, osteocytes, and cho

262 her elucidates the mechanism of autophagy in mesenchymal stem cell osteogenic differentiation.

263 Mesenchymal stem cells overexpressing Mkx promote functi

264 Both rat chondrocyte and human mesenchymal stem cell PCMs possess many unused binding s

265 Periodontal ligament mesenchymal stem cells (PDLMSCs) are responsible for reg

266 In experiments on human mesenchymal stem cells plated on soft, medium rigidity,

267 animal due to the presence of epithelial and mesenchymal stem cells-provides a model for the study of

268 LCN2 priming of mesenchymal stem cells resulted in the upregulation of R

269 te (HCCS-PDA) were examined by culturing rat mesenchymal stem cells (rMSCs) on HCCS-PDA and HCCS coat

270 iphyseal chondrocytes, marrow adipocytes and mesenchymal stem cell rosettes.

271 e (>15) showed significantly decreased HSCs, mesenchymal stem cells, Schwann cells, and neural fibers

272 tem cells (HSCs) and associated niche cells, mesenchymal stem cells, Schwann cells, neural fibers, an

273 Adult human mesenchymal stem cells show structural rearrangements of

274 stiffness of flat hydrogel surfaces induced mesenchymal stem cell spreading and proliferation; howev

275 culture conditions and during coculture with mesenchymal stem cells that mimic the AML microenvironme

276 Here, we review the biology of mesenchymal stem cells, their interaction with endogenou

277 m, including bone marrow transplantation and mesenchymal stem cell therapy, have entered into early c

278 er of fibronectin (FN), we were able to grow mesenchymal stem cells to densities comparable to those

279 The ability of mesenchymal stem cells to differentiate into mesoderm- a

280 ifferential short- and long-term response of mesenchymal stem cells to dynamic tensile loading based

281 The mechanoresponse of human mesenchymal stem cells to e-beam patterned substrates wa

282 oblasts and adipose- and bone marrow-derived mesenchymal stem cells to obtain cancer-associated fibro

283 mplished reversible differentiation of human mesenchymal stem cells to osteoblasts in a spatially def

284 own about the molecular events that initiate mesenchymal stem cells to proliferate and differentiate

285 ional program required for the commitment of mesenchymal stem cells to the adipocytic lineage.

286 hase 2A clinical trial of ischaemia-tolerant mesenchymal stem cells to treat Alzheimer's disease in t

287 itive method was developed to evaluate human mesenchymal stem cells trans-differentiation to endothel

288 RATIONALE: Umbilical cord-derived mesenchymal stem cells (UC-MSC) are easily accessible an

289 Using umbilical cord-derived mesenchymal stem cells (uMSC) from offspring born to nor

290 heterogeneity amongst both chondrocytes and mesenchymal stem cells undergoing chondrogenesis.

291 n=15) or 100 million (n=15) allogeneic human mesenchymal stem cells via transendocardial injection (0

292 differentiation of human bone marrow-derived mesenchymal stem cells was assessed.

293 In human amniotic fluid-derived mesenchymal stem cells, we show that exogenous WT1B repr

294 Human mesenchymal stem cells were dual labelled with SPIONs an

295 Furthermore, mesenchymal stem cells were isolated and cultured from 2

296 However, recent research into mesenchymal stem cells, which are commonly used in many

297 ne knockdown efficiencies in adipose derived mesenchymal stem cells with minimal cytotoxicity compare

298 -derived neural stem cells (hNSCs) and human mesenchymal stem cells with neurogenic potential from um

299 Fusion of donor mesenchymal stem cells with parenchymal cells of the rec

300 Treatment of isolated bone marrow-derived mesenchymal stem cells with SR2595 promotes induction of